Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
-104.36%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 431 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aptevo Therapeutics Inc.
Market Cap
$3.94M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.32M
Operating Margin
-162.87%
TTM Avg
-242.97%
3Y Avg
-229.35%
5Y Avg
-164.06%
Market Cap
$3.48M
Operating Margin
-364.24%
TTM Avg
-350.71%
3Y Avg
-763.84%
5Y Avg
-1461.60%
Market Cap
$3.47M
Operating Margin
-446.70%
TTM Avg
-461.82%
3Y Avg
-487.15%
5Y Avg
-381.78%
Market Cap
$4.41M
Operating Margin
0.00%
TTM Avg
-1346.57%
3Y Avg
-8443.50%
5Y Avg
-5629.00%
Market Cap
$4.42M
Operating Margin
-484.31%
TTM Avg
-1917.01%
3Y Avg
-2405.16%
5Y Avg
-1618.57%
Market Cap
$3.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-518.01%
5Y Avg
-1135.32%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | $3.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | 0.00% | 0.00% | -243.17% |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -162.87% | -242.97% | -229.35% | -164.06% |
| Evogene Ltd. (EVGN)vs › | $3.48M | -364.24% | -350.71% | -763.84% | -1461.60% |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | -446.70% | -461.82% | -487.15% | -381.78% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | 0.00% | -1346.57% | -8443.50% | -5629.00% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | -484.31% | -1917.01% | -2405.16% | -1618.57% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.44M | 0.00% | 0.00% | -518.01% | -1135.32% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -180.19% |
| 2021-12-31 | -110.23% |
| 2021-09-30 | -153.42% |
| 2021-06-30 | -183.99% |
| 2021-03-31 | -284.51% |
| 2020-12-31 | -287.36% |
| 2020-09-30 | -426.93% |
| 2020-06-30 | -1439.11% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | -85.38% |
| 2019-09-30 | -117.07% |
| 2019-06-30 | -175.22% |
| 2019-03-31 | -162.92% |
| 2018-12-31 | -214.18% |
| 2018-09-30 | -208.22% |
| 2018-06-30 | -182.30% |
| 2018-03-31 | -331.64% |
| 2017-12-31 | -596.91% |
| 2017-09-30 | -167.66% |
| 2017-06-30 | -99.18% |
| 2017-03-31 | -128.75% |
| 2016-12-31 | -340.56% |
| 2016-09-30 | -757.62% |
| 2016-06-30 | -126.02% |
| 2016-03-31 | -160.93% |
| 2015-12-31 | -223.27% |
| 2015-09-30 | -200.98% |
| 2015-06-30 | -258.25% |
| 2015-03-31 | -95.19% |
